Research Projects

Home > Research > Research Projects


We provide an overview of the current M.E. infrastructure investment and the research studies that are taking place with financial support from the MEA Ramsay Research Fund.

And, we provide position statements on the proposed UK clinical trial of Rituximab and the Post-Mortem Tissue Bank – including how you can donate tissue to M.E. Research after death.

Research Infrastructure

The ME Biobank at the Royal Free Hospital in London

The ME Association Ramsay Research Fund covers all the basic running costs of the ME Biobank and Dr Charles Shepherd is Chair of the Biobank Steering Group.

The Biobank was launched in August 2011 following extensive consultation with professionals and patient representatives.

To date the Ramsay Research Fund has invested c.£380,000 in the M.E. Biobank which will cover running costs until 2021 when we hope the project will be self-sustaining.

Read more and watch the Biobank video…

Current Research Studies

1. Dr Keith Geraghty, University of Manchester

Dr Keith Geraghty.

This study will centre around a national patient survey that will determine the factors affecting diagnosis and highlight any issues that may relate to delays in the diagnostic process…

We hope that the analysed data when published will lead to improvements in the current process that will benefit future generations.

RRF Investment = £25,000

Read more…

2. Dr Karl Morten et al. University of Oxford

Recently preliminary investigations at 3 independent laboratories highlighted that there may be an anomaly present in the blood plasma of people with ME/CFS that is adversely affecting mitochondrial performance in healthy cells.

Dr Morten and his team will attempt to determine if this anomaly can be isolated and identified. They will be working closely with Dr Pawel Zalewski from Nicolaus Copernicus University, in Poland and using samples from his own work on ME…

RRF Investment = c.£75,000

Read more…

3. Dr Keith Geraghty, University of Manchester

Critical examination of the theoretical basis that underlies the use of cognitive behaviour therapy (CBT) and graded exercise therapy (GET) in ME/CFS.

This two year award has been given to Dr Keith Geraghty at the University of Manchester and will challenge and review the theoretical basis and clinical application of CBT and GET in the NHS…

RRF investment = £25,000

Read more…

4. Dr Karl Morten et al., Universities of Oxford and Newcastle

Dr Karl Morten.

Scientists from the Universities of Oxford and Newcastle are spending 12 months analysing nearly 300 blood samples from the UK ME/CFS Biobank to look for small molecular clues known as metabolites. These are left behind after chemical reactions have taken place at a cellular level.

It is hoped that this research will identify patterns of metabolites that could help to form either a diagnostic test for ME/CFS or help to sub-group people that come under the ME/CFS umbrella…

RRF investment = £100,000

Read more…

5. Professor Elisa Oltra et al., University of Valencia, Spain

Dr Elisa Oltra

Professor Elisa Oltra and colleagues in Spain are aiming to build up a detailed picture of changes in what are called micro RNA profiles – along similar lines to what they have already discovered in people with fibromyalgia.

They are examining blood samples from the cohort of people with severe M.E. that are stored at the M.E. Biobank in London…

The research is now nearing completion and some preliminary results were presented at an international research conference in May 2018.

RRF investment = £50,000

Read more…

6. Dr Luis Nacul et al., LSHTM ME Biobank team and University College London

This research study will further examine both immune system dysfunction in ME/CFS and defects in the way that energy is being produced at a cellular level…

This new research will investigate how abnormalities in this part of the immune system are linked with evidence that is now emerging of a disturbance in the way that energy is being produced at a cellular level in ME/CFS…

It will draw on the expertise not only of the CureME clinical research team but also of other experts in immunology at the LSHTM.

This research will also involve a small pilot collaboration with Dr Christopher Armstrong’s research team in Australia – who are looking at metabolic (chemical) changes in the blood that occur during energy production…

RRF investment = c.£50,000

Read more…

Position statements:

Long-term research projects and donating to post-mortem research

1. Post mortem Tissue Sampling and the UK ME/CFS Post mortem Tissue Bank

The ME Association is the only charity involved in the collection of post mortem tissue samples from people diagnosed with ME/CFS in the UK.

Our long-term aim is to establish a national ME/CFS Post mortem Tissue Bank where greater numbers of samples can be collected and stored for vital research.

If you would like to donate post mortem tissue for ME/CFS research then you need to make this clear by completing a Statement of Intent which can be kept with your Will or in a Codicil to your Will. Your next of kin will also need to know about this instruction and where they can locate it.

Read more…

2. Rituximab

The ME Association had believed that the drug Rituximab represented the most important development in terms of a potential disease altering treatment. Early studies had indicated the drug might be effective in at least a subgroup of people with M.E.

This was until we heard the discouraging news from the phase III clinical trial in Norway at the end of 2017. Formal publication of the trial results were made in April 2019 by lead researchers, Dr Øystein Fluge and Dr Olav Mella, from Haukeland University Hospital, Bergen.

Read more…

3. The ME/CFS Disease Register

Action for M.E., the ME Association and ME Research UK jointly released a statement in 2016 updating supporters on the ME/CFS Disease Register project, which came to an end.

The maintenance and regular update of all the information held in the Disease Register is no longer a priority for the limited research funds available to us, and we explain why this is in our statement.

Read more…

The ME Association

Ramsay Research Fund

We are a national charity working hard to improve the lives of people devastated by an often-misunderstood neurological disease. 

We believe biomedical research offers the best hope to people affected by M.E. If you would like to support our investment then please donate to the Ramsay Research Fund. 

Just click the image opposite to visit our JustGiving page for single donations or to establish a regular payment. You can even establish your own fundraising event.

Or why not join the ME Association as a member and be part of our growing community? For a monthly (or annual) subscription you will also receive ME Essential – quite simply the best M.E. magazine!


ME Association Registered Charity Number 801279


Visit the other pages in this section:

  • Research Projects:
    RRF investment in infrastructure and laboratory research. Also, position statements on long-term initiatives like the Rituximab clinical trial and the Post-Mortem Tissue Bank and how you can donate tissue after death.
  • Published Research:
    RRF studies from 2000 to present; PACE Trial reanalysis and critical commentary, and MEA illness management reports and critical trial reviews; MEA research summaries and research updates.
  • Volunteering for Research:
    ME/CFS research requiring volunteers.
  • CFS/ME Research Collaborative:
    The ME Association is an active member of the Executive Board of the CMRC. Here you can learn more about this organisation, become a member, read the conference reviews, and meeting summaries.

^ Return to Top

Follow by Email
Twitter
Visit Us
Follow Me
Tweet
Instagram